BrainTale
Braintale develops and distributes diagnosis and prognosis tools for brain injured patients.
BrainTale has raised €5.5M across 2 funding rounds from 2 investors, most recently a round in Jun 2023. Based in Paris, France; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€5.5M
€5,500,000
Funding rounds
2
Investors
2
distinct backers
Active since
2020-11
latest 2023-06
Funding by year
EUR raised per yearBrainTale — funding by year — interactive chart.
Data table
| BrainTale — funding by year | |
|---|---|
| 2020 | €1.0M |
| 2023 | €4.5M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-06-20 | Other | €4.5M | Capital Grand Est,MACSF | View deal → |
| 2020-11-10 | Other | €1.0M | — | View deal → |
Investors
2Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData